Literature DB >> 22960987

The clinical features of pathologically confirmed vascular parkinsonism.

Philip George Glass1, Andrew J Lees, Aroldo Bacellar, Jan Zijlmans, Regina Katzenschlager, Laura Silveira-Moriyama.   

Abstract

OBJECTIVE: To evaluate in detail the clinical features in a large series of pathologically confirmed cases of vascular Parkinsonism (VP).
BACKGROUND: In the absence of widely accepted diagnostic criteria for VP pathological confirmation of diagnosis is necessary to ensure diagnostic reliability, and has only been reported in a few small series. DESIGN/
METHODS: The archival records of the Queen Square Brain Bank (QSBB) have been used to identify cases of Parkinsonism where cerebrovascular disease was the only pathological finding. Clinical notes were scrutinised and milestones of disease progression were compared with other atypical Parkinsonian syndromes from previous QSBB studies.
RESULTS: Twenty-eight cases were included. Mean age of onset and disease duration were 70.6 (SD± 6.42) and 10.5 (SD± 66.1) years respectively. Bradykinesia was present in all cases, rigidity in 96%, falls in 76%, pyramidal signs in 54%, urinary incontinence in 50% and dementia in 39%.Visual hallucinations in 0%. Two-thirds had an insidious onset and a relentless rather than stepwise progression of disability. When compared with other Parkinsonian syndromes, VP had an older age of onset.
CONCLUSIONS: In comparison with other Parkinsonian syndromes the patients were older and had an extremely low frequency of visual hallucinations compared with Parkinson's disease.

Entities:  

Mesh:

Year:  2012        PMID: 22960987     DOI: 10.1136/jnnp-2012-302828

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

Review 1.  An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Authors:  Ivan Rektor; Nicolaas I Bohnen; Amos D Korczyn; Viktoria Gryb; Hrishikesh Kumar; Milica G Kramberger; Frank-Erik de Leeuw; Zvezdan Pirtošek; Irena Rektorová; Ilana Schlesinger; Jaroslaw Slawek; Peter Valkovič; Branislav Veselý
Journal:  Parkinsonism Relat Disord       Date:  2017-12-29       Impact factor: 4.891

2.  Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.

Authors:  Megan K Herbert; H Bea Kuiperij; Bastiaan R Bloem; Marcel M Verbeek
Journal:  J Neurol       Date:  2013-12       Impact factor: 4.849

3.  Auditory and visual hallucinations after influenza vaccine: a case report.

Authors:  Stefania Antoniazzi; Carla Carnovale; Aurelio Sessa; Marta Gentili; Marco Matacena; Maurizia Punginelli; Emilio Clementi; Sonia Radice
Journal:  Ther Adv Vaccines       Date:  2016-10-21

4.  Cerebrovascular pathology presenting as corticobasal syndrome: An autopsy case series of "vascular CBS".

Authors:  Shunsuke Koga; Shanu F Roemer; Koji Kasanuki; Dennis W Dickson
Journal:  Parkinsonism Relat Disord       Date:  2019-09-02       Impact factor: 4.891

Review 5.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

Review 6.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10

7.  Nocturnal manifestations of atypical and vascular parkinsonism: how do they differ from Parkinson's disease?

Authors:  Roongroj Bhidayasiri; Onanong Jitkritsadakul; Sitthi Petchrutchatachart; Lalita Kaewwilai; Pattamon Panyakaew; Nonglak Boonrod; Carlo Colosimo
Journal:  J Neural Transm (Vienna)       Date:  2014-03-26       Impact factor: 3.575

8.  Cerebrovascular pathology and misdiagnosis of multiple system atrophy: An autopsy study.

Authors:  Shunsuke Koga; Shanu F Roemer; Philip W Tipton; Phillip A Low; Keith A Josephs; Dennis W Dickson
Journal:  Parkinsonism Relat Disord       Date:  2020-05-16       Impact factor: 4.402

Review 9.  Neuroimaging in Vascular Parkinsonism.

Authors:  Karen K Y Ma; Shi Lin; Vincent C T Mok
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

10.  Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study.

Authors:  Angela E P Bouwmans; Albert F G Leentjens; Werner H Mess; Wim E J Weber
Journal:  Parkinsons Dis       Date:  2016-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.